These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 28254487)

  • 1. Synthesis and biological evaluation of C-3 aliphatic coumarins as vitamin K antagonists.
    Montagut-Romans A; Boulven M; Jacolot M; Moebs-Sanchez S; Hascoët C; Hammed A; Besse S; Lemaire M; Benoit E; Lattard V; Popowycz F
    Bioorg Med Chem Lett; 2017 Apr; 27(7):1598-1601. PubMed ID: 28254487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and structure-activity relationships of novel warfarin derivatives.
    Gebauer M
    Bioorg Med Chem; 2007 Mar; 15(6):2414-20. PubMed ID: 17275317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The in vivo effects of oral anticoagulants in man: comparison between liver and non-hepatic tissues.
    de Boer-van den Berg M; Thijssen HH; Vermeer C
    Thromb Haemost; 1988 Apr; 59(2):147-50. PubMed ID: 3260413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin K antagonism of coumarin intoxication in the rat.
    Wallin R; Patrick SD; Ballard JO
    Thromb Haemost; 1986 Apr; 55(2):235-9. PubMed ID: 2424118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin K 2,3-epoxide reductase: the basis for stereoselectivity of 4-hydroxycoumarin anticoagulant activity.
    Thijssen HH; Baars LG; Vervoort-Peters HT
    Br J Pharmacol; 1988 Nov; 95(3):675-82. PubMed ID: 3207986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of coumarin action: sensitivity of vitamin K metabolizing enzymes of normal and warfarin-resistant rat liver.
    Hildebrandt EF; Suttie JW
    Biochemistry; 1982 May; 21(10):2406-11. PubMed ID: 6807339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of 3-amino-4-hydroxy coumarin and dihydroxy-phenyl coumarins as novel anticoagulants.
    Danis O; Yuce-Dursun B; Gunduz C; Ogan A; Sener G; Bulut M; Yarat A
    Arzneimittelforschung; 2010; 60(10):617-20. PubMed ID: 21125812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, anticoagulant and PIVKA-II induced by new 4-hydroxycoumarin derivatives.
    Abdelhafez OM; Amin KM; Batran RZ; Maher TJ; Nada SA; Sethumadhavan S
    Bioorg Med Chem; 2010 May; 18(10):3371-8. PubMed ID: 20435480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of action of coumarins. Significance of vitamin K epoxide.
    Sadowski JA; Suttie JW
    Biochemistry; 1974 Aug; 13(18):3696-9. PubMed ID: 4853124
    [No Abstract]   [Full Text] [Related]  

  • 10. Recent findings in understanding the biological function of vitamin K.
    Uotila L; Suttie JW
    Med Biol; 1982 Feb; 60(1):16-24. PubMed ID: 6803084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assay of coumarin antagonists of vitamin K in blood by high-performance liquid chromatography.
    Shearer MJ
    Methods Enzymol; 1986; 123():223-34. PubMed ID: 3702715
    [No Abstract]   [Full Text] [Related]  

  • 12. A cell-based high-throughput screen identifies drugs that cause bleeding disorders by off-targeting the vitamin K cycle.
    Chen X; Li C; Jin DY; Ingram B; Hao Z; Bai X; Stafford DW; Hu K; Tie JK
    Blood; 2020 Aug; 136(7):898-908. PubMed ID: 32374827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consequences of the Y139F Vkorc1 mutation on resistance to AVKs: in-vivo investigation in a 7th generation of congenic Y139F strain of rats.
    Grandemange A; Kohn MH; Lasseur R; Longin-Sauvageon C; Berny P; Benoit E
    Pharmacogenet Genomics; 2009 Oct; 19(10):742-50. PubMed ID: 19752778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of vitamin K antagonism by warfarin, difenacoum and brodifacoum in the rabbit.
    Park BK; Leck JB
    Biochem Pharmacol; 1982 Nov; 31(22):3635-9. PubMed ID: 7181945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and pharmacological investigations of some 4-hydroxycoumarin derivatives.
    Manolov I; Danchev ND
    Arch Pharm (Weinheim); 2003 Apr; 336(2):83-94. PubMed ID: 12761761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Puerarin offsets the anticoagulation effect of warfarin in rats by inducing rCyps, upregulating vitamin K epoxide reductase and inhibiting thrombomodulin.
    Ge B; Zhang Z; Lam TT; Zuo Z
    Biopharm Drug Dispos; 2017 Jan; 38(1):33-49. PubMed ID: 27925234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring of antivitamin K-dependent anticoagulation in rodents - Towards an evolution of the methodology to detect resistance in rodents.
    Lefebvre S; Hascoët C; Damin-Pernik M; Rannou B; Benoit E; Lattard V
    Pestic Biochem Physiol; 2017 May; 138():29-36. PubMed ID: 28456301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cellular system for quantitation of vitamin K cycle activity: structure-activity effects on vitamin K antagonism by warfarin metabolites.
    Haque JA; McDonald MG; Kulman JD; Rettie AE
    Blood; 2014 Jan; 123(4):582-9. PubMed ID: 24297869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin K antagonism of coumarin anticoagulation. A dehydrogenase pathway in rat liver is responsible for the antagonistic effect.
    Wallin R
    Biochem J; 1986 Jun; 236(3):685-93. PubMed ID: 3098238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural Modeling Insights into Human VKORC1 Phenotypes.
    Czogalla KJ; Watzka M; Oldenburg J
    Nutrients; 2015 Aug; 7(8):6837-51. PubMed ID: 26287237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.